cell-free DNA

Jul 18, 2022

GenDx Licenses cfDNA Assay for Rejection Monitoring From Medical College of Wisconsin

Jul 8, 2022

BillionToOne, UCSD Partner to Assess New Liquid Biopsy Assays in Lung Cancer

Jun 1, 2022

Epic Sciences Raises $43M in Series F Round

Jun 1, 2022

BioCaptiva Raises £2.1M in Seed Financing to Advance Liquid Biopsy Capture Device

May 19, 2022

Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE

May 18, 2022

Lucence Publishes Clinical Validation of LiquidHallmark Circulating Tumor DNA Test, Expands to RNA
Premium

May 17, 2022

Mirvie Raises $60M in Series B Funding

May 9, 2022

Artemis DNA to Provide Datar Cancer Genetics Liquid Biopsy Tests in the US, Vietnam Under $250M Deal

Apr 28, 2022

Mirvie Developing Cell-Free RNA Blood Tests to Predict Pregnancy Complications
Premium

Apr 20, 2022

Natera Adds Clinical Utility Evidence for Cell-Free DNA in Allograft Health
Premium

Mar 30, 2022

BillionToOne Raises $125M in Series C Funding Round

Feb 2, 2022

Cell-Free DNA Assay Shows Promise for Detecting Stem Cell Transplant Complications
Premium

Dec 23, 2021

Oncocyte Switches Gears on Transplant Test Commercialization, Plans to Launch LDT Next Year
Premium

Aug 27, 2021

Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech
Premium

Aug 11, 2021

Oncocyte Updates Plans for Chronix Transplant Tech; Will Develop and Market Kits in Europe
Premium

Aug 5, 2021

Karius Cell-Free DNA Method to Detect Infection Validated in Study
Premium

Jul 1, 2021

BillionToOne Adapting Fetal Dx Tech for Liquid Biopsy, Cancer Therapy Response Monitoring
Premium

Jun 15, 2021

South Korean Firm EDGC to Expand Reach Into Liquid Biopsy Space With Cell-Free DNA Platform
Premium

Jun 14, 2021

BillionToOne Raises $55M in Series B Financing

May 2, 2021

Freenome Eyes New Dx Possibilities for Core Technology as CRC Detection Trial Progresses
Premium